News

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
A newer COVID-19 variant may be causing a severe sore throat in those who contract the infections. Here's what to know about ...
In the UK, the NHS advises that Covid vaccinations are currently unavailable to the public until the early winter roll out, and only to those who need extra protection from the virus. The NHS will get ...
"These viruses are so closely related to MERS, so we have to be concerned if they ever infect humans," said virologist Michael Letko.
In this work, researchers used the spike protein itself as the marker or “antenna” to tag all the receptor sites in the vicinity of ACE2. “Alex had this great instinct that there’s other things apart ...
The spike protein is found on the surface of SARS-CoV-2, the virus that causes COVID-19. Spike proteins latch onto receptors known as angiotensin-converting enzyme 2 (ACE2) on target cells. The ...
Studies of coronaviruses indicate that spike-ACE2 recognition is the basis for infection. The researchers focused on screening the mutations located where the spike protein and ACE2 receptor meet.
Mutations at these sites alter the protein structure and neutralize the ability of monoclonal antibodies to bind with the spike protein of SARS-CoV-2 while maintaining ACE2 affinity.
In this case, the team placed SARS-CoV-2 Spike protein and ACE2 receptors in heavy water and obtained footprints of ACE2 on the Spike protein.